GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » COGS-to-Revenue

Nuvation Bio (Nuvation Bio) COGS-to-Revenue : 0.00 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio COGS-to-Revenue?

Nuvation Bio's Cost of Goods Sold for the three months ended in Sep. 2021 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2021 was $0.00 Mil.

Nuvation Bio's COGS to Revenue for the three months ended in Sep. 2021 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nuvation Bio's Gross Margin % for the three months ended in Sep. 2021 was N/A%.

Nuvation Bio COGS-to-Revenue Historical Data

The historical data trend for Nuvation Bio's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio COGS-to-Revenue Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
COGS-to-Revenue
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
COGS-to-Revenue Get a 7-Day Free Trial - - - - -

Nuvation Bio COGS-to-Revenue Calculation

Nuvation Bio's COGS to Revenue for the fiscal year that ended in Dec. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Nuvation Bio's COGS to Revenue for the quarter that ended in Sep. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio  (NYSE:NUVB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nuvation Bio's Gross Margin % for the three months ended in Sep. 2021 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Nuvation Bio COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » COGS-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.